Meetings - The ASCO Post

This is Part 3 of Later-Line Considerations in Relapsed/Refractory Renal Cell Carcinoma, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this vid...

kidney cancer

/ Later-Line Considerations in Relapsed Refractory Renal Cell Carcinoma

Refractory RCC After Disease Progression on Adjuvant IO Therapy

This is Part 2 of Later-Line Considerations in Relapsed/Refractory Renal Cell Carcinoma, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this vid...

kidney cancer

/ Later-Line Considerations in Relapsed Refractory Renal Cell Carcinoma

Metastatic Favorable-Risk RCC After Progression on VEGF/IO Therapy

This is Part 1 of Later-Line Considerations in Relapsed/Refractory Renal Cell Carcinoma, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this vid...

Later-Line Considerations in Relapsed Refractory Renal Cell Carcinoma

Metastatic RCC After Disease Progression on VEGF/IO Therapy

Refractory RCC After Disease Progression on Adjuvant IO Therapy

Metastatic Favorable-Risk RCC After Progression on VEGF/IO Therapy

Addition of Hyperthermic Intraperitoneal Chemotherapy to Surgery for Recurrent Ovarian Cancer

Penpulimab Combination Therapy for First-Line Treatment of Hepatocellular Carcinoma

Global Adaptive Platform Trial for Glioblastoma to Evaluate Novel ATM Kinase Inhibitor

Healthy Women May Have Aneuploid Epithelial Cells Resembling Breast Cancer

Perioperative Toripalimab in Locoregionally Advanced Nasopharyngeal Carcinoma